TORONTO, June 14 /CNW/ - Dalton Pharma Services, a privately owned
Canadian pharmaceutical services provider to leading pharmaceutical companies,
today announced the company has entered into a long term Manufacturing
Services Agreement with X-GEN Pharmaceuticals, Inc., a specialty pharma
company based in Big Flats, New York, focused on providing quality therapeutic
options in both specialized disease areas and broad range treatment choices.
Dalton Pharma Services has been contracted to fill/finish under cGMP,
sterile commercial products for X-GEN. The two companies, aligned in core
values and business practices are tactically poised for growth in the area of
"Our Establishment License from Health Canada, combined with our expert
capabilities in analytical services and sterile manufacturing capacity,
solidified the manufacturing agreement," said Peter Pekos, President and CEO.
"This agreement validates Dalton's customer oriented approach to bringing our
clients' products to the market quickly. We are extremely pleased to be
working with X-GEN Pharmaceuticals, and look forward to providing further
commercial manufacturing services for X-GEN, a strategic partner for Dalton,"
Susan Badia, President and Chief Executive Officer of X-GEN remarked,
"The partnership with Dalton is an example of X-GEN's commitment to expanding
our offering of pharmaceutical products which benefit the healthcare community
as reliable, cost-effective treatment choices. We are excited about the
opportunity to partner with a company whose client focus and commitment to
quality match our own. Sharing these values with partners like Dalton is vital
to our ability to provide products which fulfill the therapeutic needs of
physicians and their patients."
About Dalton Pharma Services
Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health
Canada approved, contract pharmaceutical manufacturer that supplies chemistry
and analytical services to the biotechnology and pharmaceutical industries in
the areas of medicinal chemistry, fine chemical manufacture, custom peptides
and antisense oligo production. Dalton provides cGMP manufacturing and sterile
filling services to its customers at any stage of the regulatory process
(Phase I, II, III or commercial). In its state of the art cGMP facilities,
Dalton can produce active pharmaceutical ingredients (API), at the gram or
kilogram scale. Dalton can carry out sterile fills to produce batches of
finished drug product in vials or syringes, either aseptically filled or
terminally sterilized, under fully validated conditions. In addition to drug
testing, Dalton's analytical chemistry laboratory offers method development,
validation, ICH stability programs and HPLC-MS services to its clients.
About X-Gen Pharmaceuticals Inc.
X-GEN Pharmaceuticals, Inc. is a generic drug company specializing in the
manufacturing and distribution of mature anti-infective pharmaceutical
products. X-GEN's strategic focus is on the continuous development of quality
generic pharmaceuticals which enhance patient care as reliable and affordable
treatment options. X-GEN's product offering includes a broad range of dosage
forms, including injectables, topical solutions, oral solutions, oral solids,
powders for prescription compounding and inhalants.
For further information:
For further information: Peter Pekos, Dalton Pharma Services, Tel: (416)
661-2102, Fax: (416) 661-2108, email@example.com